David Alan Campbell Janux Therapeutics, Inc. (JANX) insider trading activity

David Alan Campbell is President and CEO of Janux Therapeutics, Inc.. Currently has a direct ownership of 293,054 shares of JANX, which is worth approximately $12.9 Million. The most recent transaction as insider was on Jan 07, 2025, when has been sold 5,000 shares (Common Stock) at a price of $60.0 per share, resulting in proceeds of $300,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 293K

4.56% 3M change

n/a 12M change

Total Value Held $12.9 Million

David Alan Campbell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 07 2025	SELL Open market or private sale	$300,000 $60.0 p/Share	5,000 Reduced 1.68%	293,054 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	81,000 Added 21.37%	298,054 Common Stock
Dec 24 2024	SELL Open market or private sale	$1,404,750 $56.19 p/Share	25,000 Reduced 10.33%	217,054 Common Stock
Dec 03 2024	SELL Open market or private sale	$1,005,000 $67.0 p/Share	15,000 Reduced 5.84%	242,054 Common Stock
Nov 25 2024	SELL Open market or private sale	$1,293,500 $51.74 p/Share	25,000 Reduced 8.86%	257,054 Common Stock
Oct 28 2024	SELL Open market or private sale	$1,339,500 $53.58 p/Share	25,000 Reduced 8.14%	282,054 Common Stock
Sep 27 2024	SELL Open market or private sale	$1,173,250 $46.93 p/Share	25,000 Reduced 7.53%	307,054 Common Stock

DAC

David Alan Campbell

President and CEO

La Jolla, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Value

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Janux Therapeutics, Inc.

Track Activities on JANX

Account